Pabillar, Janille .

HRN: 29-46-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/14/2026
08/21/2026
IV
500
Q8
Thickly Msaf
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines